Sign in to confirm you’re not a bot
This helps protect our community. Learn more

Soligenix $SNGX HyBryte™ Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding

Benzinga Partner Studio
2.75K subscribers
503 views 1 month ago
Discover how Soligenix’s skin cancer treatment, HyBryte™, is delivering fast, safe, and effective results in clinical trials. Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. https://www.soligenix.com/   / soligenix     / soligenix-inc-     / soligenix   https://x.com/Soligenix_Inc ...more
...more
Soligenix $SNGX HyBryte™ Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding
1Likes
503Views
Apr 232025
Discover how Soligenix’s skin cancer treatment, HyBryte™, is delivering fast, safe, and effective results in clinical trials. Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. https://www.soligenix.com/   / soligenix     / soligenix-inc-     / soligenix   https://x.com/Soligenix_Inc

Follow along using the transcript.

Benzinga Partner Studio

2.75K subscribers